TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 4 | 1 | -11 | -39 | -46 | -54 | -24 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/4/08 20:15 | 1/31/08 | CCYG | Cellcyte Genetics Corp | NV | Health | Drug | Pharmaceutical Preparations | Fluke John M Jr | WA | D | P | 2 | 0.4700 | 0 | 4 | 8 | 54 | D | |||||||||||||||
1/31/08 17:32 | 1/30/08 | CCYG | Cellcyte Genetics Corp | NV | Health | Drug | Pharmaceutical Preparations | Fluke John M Jr | WA | D | P | 1 | 0.5400 | 0 | 1 | 2 | 50 | D | |||||||||||||||
1/30/08 14:04 | 1/29/08 | CCYG | Cellcyte Genetics Corp | NV | Health | Drug | Pharmaceutical Preparations | Fluke John M Jr | WA | D | P | 1 | 0.5800 | 0 | 1 | 2 | 49 | D | |||||||||||||||
1/29/08 13:24 | 1/24/08 | CCYG | Cellcyte Genetics Corp | NV | Health | Drug | Pharmaceutical Preparations | Fluke John M Jr | WA | D | P.m | 4 | 0.9100 | 0 | 4 | 9 | 48 | D | |||||||||||||||
3/16/05 18:19 | 3/14/05 | CTIC | Cell Therapeutics Inc | WA | Health | Drug | Pharmaceutical Preparations | Fluke John M Jr | WA | D | P | 20 | 4.00 | 0 | 5 | 100 | 10 | D | -43 | -48 | -34 | -47 | -58 | -60 | -58 | -15 | 4 | 1 | -11 | -39 | -46 | -54 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |